BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6696460)

  • 41. High concentrations of activin A in the peritoneal fluid of women with epithelial ovarian cancer.
    Cobellis L; Reis FM; Luisi S; Danero S; Pirtoli L; Scambia G; Petraglia F
    J Soc Gynecol Investig; 2004 May; 11(4):203-6. PubMed ID: 15120692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Differential cytologic diagnosis of serous and mucinous ovarian tumors].
    Agamova KA; Gladunova ZD; Nikitina NI
    Lab Delo; 1986; (2):77-9. PubMed ID: 2421066
    [No Abstract]   [Full Text] [Related]  

  • 44. TPS and CA 125 levels in serum, cyst fluid and ascites of patients with epithelial ovarian neoplasms.
    Harłozinska A; Sedlaczek P; Van Dalen A; Rozdolski K; Einarsson R
    Anticancer Res; 1997; 17(6D):4473-8. PubMed ID: 9494553
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Serous papillary cystadenoma of the rectum].
    Karseladze AI; Vinogradov AL
    Arkh Patol; 1985; 47(11):71-4. PubMed ID: 4091700
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neurohormonal peptide immunoreactive cells in mucinous cystadenomas and cystadenocarcinomas of the ovary.
    Sporrong B; Alumets J; Clase L; Falkmer S; Håkanson R; Ljungberg O; Sundler F
    Virchows Arch A Pathol Anat Histol; 1981; 392(3):271-80. PubMed ID: 6115500
    [No Abstract]   [Full Text] [Related]  

  • 47. Prostate-derived Ets factor is overexpressed in serous epithelial ovarian tumors.
    Rodabaugh KJ; Mhawech-Fauceglia P; Groth J; Lele S; Sood AK
    Int J Gynecol Pathol; 2007 Jan; 26(1):10-5. PubMed ID: 17197890
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Serous and mucinous ovarian cystadenomas at the limit of malignancy].
    Chenevart P; Gloor E
    Schweiz Med Wochenschr; 1980 Apr; 110(14):531-9. PubMed ID: 7375903
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions.
    Stadlmann S; Amberger A; Pollheimer J; Gastl G; Offner FA; Margreiter R; Zeimet AG
    Gynecol Oncol; 2005 Jun; 97(3):784-9. PubMed ID: 15943987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Expression of the cdx2 gene in benign intestinal-type mucinous ovarian tumors].
    Gaggero G; Sola S; Mora M; Fulcheri E
    Pathologica; 2003 Aug; 95(4):185-91. PubMed ID: 14577202
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cytophotometric determination of DNA concentration in the process of malignant degeneration of serous ovarian cysts].
    Irzhanov SI
    Vopr Onkol; 1971; 17(3):52-4. PubMed ID: 5563178
    [No Abstract]   [Full Text] [Related]  

  • 52. Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary.
    Chudecka-Głaz A; Rzepka-Górska I; Kosmowska B
    Arch Gynecol Obstet; 2004 Nov; 270(3):151-6. PubMed ID: 12883823
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Diagnostic significance of ferritin assay in peritoneal fluid and gastric juice].
    Krylov IuV; Malashenko SV; Medvedev MN; Mikhaĭlova EI
    Vopr Onkol; 2002; 48(1):88-90. PubMed ID: 12101576
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Value of ascitic fluid ferritin in the differential diagnosis of malignant ascites.
    Kountouras J; Boura P; Tsapas G; Charisis K; Magoula I; Tsakiri I
    Anticancer Res; 1993; 13(6B):2441-5. PubMed ID: 8135481
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ultrastructural study of benign, low-malignant potential (LMP), and malignant ovarian tumors.
    Ishioka S; Sagae S; Ito E; Kudo R
    Med Electron Microsc; 2004 Mar; 37(1):37-44. PubMed ID: 15057603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Soluble receptor for urokinase plasminogen activator in both full-length and a cleaved form is present in high concentration in cystic fluid from ovarian cancer.
    Wahlberg K; Høyer-Hansen G; Casslén B
    Cancer Res; 1998 Aug; 58(15):3294-8. PubMed ID: 9699658
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunohistochemical similarities between pancreatic mucinous cystic tumor and ovarian mucinous cystic tumor.
    Suzuki Y; Sugiyama M; Abe N; Fujioka Y; Atomi Y
    Pancreas; 2008 Jan; 36(1):e40-6. PubMed ID: 18192871
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Morphological and immunological heterogeneity of human ovarian neoplasms.
    Harłozińska A; Rabczyński J; Bar JK; Richter R
    Arch Immunol Ther Exp (Warsz); 1991; 39(4):419-29. PubMed ID: 1821619
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fibrin-fibronectin compounds in human ovarian tumor ascites and their possible relation to the tumor stroma.
    Wilhelm O; Hafter R; Coppenrath E; Pflanz MA; Schmitt M; Babic R; Linke R; Gössner W; Graeff H
    Cancer Res; 1988 Jun; 48(12):3507-14. PubMed ID: 3130986
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ovarian giant cell tumor with cystadenocarcinoma.
    Veliath AJ; Sankaran V; Aurora AL
    Arch Pathol; 1975 Sep; 99(9):488-91. PubMed ID: 1164251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.